Predictive value of proliferation-related markers, p53, and DNA ploidy for survival in patients with soft tissue spindle-cell sarcomas

Modern Pathology

Volumn 9, Issue 9, 1996, Pages 919-924

  Golouh, Rastko ^a   Bračko, Matej ^a   Novak, Janez ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

DNA ploidy; Immunohistochemistry; P53 Protein; Prognosis; Proliferation markers; Soft tissue sarcomas

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY KI 67; PROTEIN P53;

ADULT; AGED; ARTICLE; CHILD; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; SPINDLE CELL SARCOMA; SURVIVAL;

CELL DIVISION; DNA, NEOPLASM; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MULTIVARIATE ANALYSIS; PLOIDIES; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029744253     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Coindre J-M, Binh Bui N, Bonichon F, de Mascarel I, Trojani M: Histopathologic grading in spindle cell soft tissue sarcomas. Cancer 61:2305, 1988
2. Ueda T, Aozasa K, Tsujimoto M: Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 63:1607, 1989
3. Iwasaki H, Yoshitake K, Ohjimi Y, et al.: Malignant fibrous histiocytoma. Proliferative compartment and heterogeneity of "histiocytic" cells. Am J Surg Pathol 16:735, 1992
4. Soini YS, Vähäkangas K, Nuorva K, et al.: p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours. J Pathol 168:29, 1992
5. Drobnjak M, Latres E, Pollack D, et al.: Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft tissue sarcomas. J Natl Cancer Inst 86:549, 1994
6. Kawai A, Noguchi M, Beppu Y, et al.: Nuclear immunoreaction of p53 protein in soft tissue sarcomas: A possible prognostic factor. Cancer 73:2499, 1994
7. Taylor SR, Blatt J, Costantino JP, Roederer M, Murphy RF: Flow cytometric DNA analysis of neuroblastoma and ganglioneuroblastoma: A 10-year retrospective study. Cancer 62: 749, 1988
8. Kowal-Vern A, Gonzales-Crussi F, Turner J, et al.: Flow and image cytometric DNA analysis in rhabdomyosarcoma. Cancer Res 50:6023, 1990
9. Chou P, Shen-Schwarz S, Mangkornkanok M, Crawford S, Gonzales-Crussi F: DNA analysis of genitourinary rhabdomyosarcoma in children. Surg Pathol 4:145, 1991
10. Shapiro DN, Parham DM, Douglass EC, et al.: Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma. J Clin Oncol 9:159, 1991
11. Bauer HCF, Kreicbergs A, Tribukait B: DNA content prognostic in soft tissue sarcoma: 102 patients followed for 1-10 years. Acta Orthop Scand 62:187, 1991
12. Alvegård TA, Berg NO, Baldetrop B, et al.: Cellular DNA content and prognosis in high-grade soft tissue sarcoma: The Scandinavian Sarcoma Group experience. J Clin Oncol 8:538, 1990
13. Enzinger FM, Weiss SW: Soft Tissue Tumors, Ed. 3. St. Louis, Mosby, 1995
14. Fletcher CD: Pleomorphic malignant fibrous histiocytoma: Fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 16: 213, 1992
15. Costa J, Wesley RA, Glatstein E, Rosenberg SA: The grading of soft tissue sarcomas. Results of a clinicopathologic correlation in a series of 163 cases. Cancer 53:530, 1984
16. Heiden T, Wang N, Tribukait B: An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry 12:614, 1991
17. Michie BA, Black C, Reid RP, Barrett A, Hamblen DL: Image analysis derived ploidy and proliferation indices in soft tissue sarcomas: Comparison with clinical outcome. J Clin Pathol 47:443, 1994
18. Choong PF, Akerman M, Willen H, et al.: Prognostic value of Ki-67 expression in 182 soft tissue sarcomas: Proliferation - a marker of metastasis? APMIS 102:915, 1994
19. Yang P, Hirose T, Hasegawa T, et al.: Prognostic implication of the p53 protein and Ki-67 antigen immunohistochemistry in malignant fibrous histiocytoma. Cancer 76:618, 1995
20. Golouh R, Bračko M: Proliferation markers, p53 expression and DNA ploidy in retroperitoneal spindle-cell sarcomas (abstract). Int J Surg Pathol 2(Suppl):573, 1995
21. Dreinhöfer KE, Åkerman M, Willén H, et al.: Proliferating cell nuclear antigen (PCNA) in high-grade malignant fibrous histiocytoma: Prognostic value in 48 patients. Int J Cancer 59:379, 1994
22. Oda Y, Hashimoto H, Takeshita S, Tsuneyoshi M: The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma. Cancer 72: 478, 1993
23. Zehr RJ, Bauer TW, Marks KE, Weltevreden A: Ki-67 and grading of malignant fibrous histiocytomas. Cancer 66:1984, 1990
24. Gelb AB, Kamel OW, Le Brun DP, Warnke RA: Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/cyclin monoclonal antibodies. Factors affecting reactivity. Am J Pathol 141:1453, 1992
25. Coltrera MD, Skelly M, Gown AM. Anti-PCNA antibody PC10 yields unreliable proliferation indexes in routinely processed, deparaffinized, formalin-fixed tissue. Appl Immunohistochem 1:193, 1993
26. Kindblom L-G, Meis-Kindblom JM: Chondroid lipoma: An ultrastructural and immunohistochemical analysis with further observation regarding its differentiation. Hum Pathol 26:706, 1995
27. Kindblom L-G, Ahlden M, Meis-Kindblom JM: Immunohistochemical and molecular analysis of p53 MDM2 PCNA, and Ki67 in benign and malignant peripheral nerve sheath tumors. Virchows Arch 427:19, 1995
28. Wadayama B, Toguchida J, Yamaguchi T, et al.: p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer 68:1134, 1993
29. Latres E, Drobnjak M, Pollack D, et al.: Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas. Am J Pathol 145:345, 1994
30. Dei Tos AP, Doglioni C, Laurino L, Barbareschi M, Fletcher CD: p53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissue. Histopathology 22:45, 1993
31. Batsakis JG, El-Naggar AK: p53: Fifteen years after discovery. Adv Anat Pathol 2:71, 1995
32. Bračko M, Golouh R, Us-Krašovec M: DNA flow cytometry of malignant fibrous histiocytoma and other pleomorphic sarcomas (abstract). Anal Cell Pathol 6:231, 1994